Key Insights

Highlights

Success Rate

95% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

2.6%

2 terminated out of 76 trials

Success Rate

94.6%

+8.1% vs benchmark

Late-Stage Pipeline

29%

22 trials in Phase 3/4

Results Transparency

11%

4 of 35 completed with results

Key Signals

4 with results95% success

Data Visualizations

Phase Distribution

60Total
Not Applicable (10)
Early P 1 (2)
P 1 (14)
P 2 (12)
P 3 (7)
P 4 (15)

Trial Status

Completed35
Unknown24
Recruiting8
Withdrawn3
Not Yet Recruiting2
Active Not Recruiting2

Trial Success Rate

94.6%

Benchmark: 86.5%

Based on 35 completed trials

Clinical Trials (76)

Showing 20 of 20 trials
NCT07154719Phase 4Recruiting

GLP-1R Actions on Muscle and the Skeleton

NCT06658197Phase 3Recruiting

Efficacy and Safety of Tenecteplase Bridging Mechanical Thrombectomy for Acute Large Vessel Occlusion Stroke

NCT05796362Phase 1Completed

A Single-Dose, Three-Way, Three-Sequence, Crossover BA Study of Azithromycin Oleogel

NCT05512169Recruiting

Pharmacogenomic Association Study in Indian Children With Acute Lymphoblastic Leukemia

NCT03593408RecruitingPrimary

Pharmacokinetics of Sedatives and Analgesics During Extracorporeal Membrane Oxygenation (ECMO) Support

NCT07182942Phase 4Recruiting

The Effect and Mechanism of Xiqing Regulating Intestinal Homeostasis on Drug Efficacy of Chronic Kidney Disease

NCT05335915Phase 1Completed

Acute Pharmacokinetic and Pharmacodynamic Effects of "Tobacco-Free" Oral Nicotine Pouches in Smokers

NCT03532399RecruitingPrimary

Pharmacokinetics of Bivalirudin for Pediatric Anticoagulation

NCT05578586Not ApplicableRecruitingPrimary

A Pilot Study for Optimizing Meropenem Administration in the ICU

NCT06856772Phase 4Not Yet Recruiting

Randomized Comparison of Morning Versus Bedtime Administration of Statins: A Cardiovascular Circadian Chronotherapy (C3) Trial

NCT04387201Phase 4Completed

GLP-1 Therapy: The Role of IL-6 Signaling and Adipose Tissue Remodeling in Metabolic Response

NCT05300152Not ApplicableCompletedPrimary

Pulpotomy Medications in Primary Teeth

NCT05840913Phase 2CompletedPrimary

Different Volumes of Articaine for Inferior Alveolar Nerve Block in Irreversible Pulpitis

NCT06594172Phase 2Not Yet Recruiting

Early Application of Memantine and Pioglitazone to Protect Cognitive Function After Radiotherapy

NCT06238154Phase 4Completed

Flurbiprofen Tablet vs Spray In Oral Soft Tissue Wounds

NCT06501248Phase 3Unknown

Effect of Triticum Aestivum vs Placebo on Metabolic Profile Components and Insulin Sensitivity in Patients With Obesity

NCT06497036Phase 3Active Not RecruitingPrimary

Study of Efficacy, Safety and Immunogenicity of GP40141 (GEROPHARM, Russia) in Patients With Immune Thrombocytopenia

NCT06485817Not ApplicableCompleted

How Stress Alters Opioid Drug Effects

NCT06413082Phase 3Completed

Pharmacogenetics of Torasemide and Spironolactone in Hypertension Treatment

NCT04254731Phase 4Active Not Recruiting

Effects of Switching From Racemic Methadone to R-methadone on QTc Intervals

Scroll to load more

Research Network

Activity Timeline